Market Exclusive

Analyst Activity – BMO Capital Markets Reiterates Underperform on Bristol-Myers Squibb Company (NYSE:BMY)

Analyst Ratings For Bristol-Myers Squibb Company (NYSE:BMY)

Today, BMO Capital Markets reiterated its Underperform rating on Bristol-Myers Squibb Company (NYSE:BMY) with a price target of $47.00.

There are 1 sell rating, 10 hold ratings, 10 buy ratings on the stock.

The current consensus rating on Bristol-Myers Squibb Company (NYSE:BMY) is Hold (Score: 2.43) with a consensus target price of $63.06 per share, a potential 12.71% upside.

Some recent analyst ratings include

Dividend information for Bristol-Myers Squibb Company (NYSE:BMY)

Bristol-Myers Squibb Company (NYSE:BMY) pays an annual dividend of Community Ranking: with a yield of 2.79% and an average dividend growth of 2.80% based on a 3 Year Average.

Dividend History for Bristol-Myers Squibb Company (NYSE:BMY)

Recent Insider Trading Activity For Bristol-Myers Squibb Company (NYSE:BMY)
Bristol-Myers Squibb Company (NYSE:BMY) has insider ownership of 0.23% and institutional ownership of 69.72%.

Recent Trading Activity for Bristol-Myers Squibb Company (NYSE:BMY)
Shares of Bristol-Myers Squibb Company closed the previous trading session at 55.66 down -0.29 -0.52% with 7,312,939 shares trading hands.

Exit mobile version